Biostatistics and Data Management Section

生物统计和数据管理科

• 批准号: 10262817
• 负责人: SETH M STEINBERG
• 金额: $ 95.13万
• 依托单位: DIVISION OF CLINICAL SCIENCES - NCI
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10262817
• 关键词: AIDS/HIV problem; Acquired Immunodeficiency Syndrome; Biometry; Clinical Treatment; Clinical Trials; Collaborations; Component of the Center for Cancer Research; Consultations; Data Analyses; Development; Diagnostic Procedure; Evaluation; Growth; In Vitro; Laboratories; Leadership; Malignant Neoplasms; Methods; Monitor; Multi-Institutional Clinical Trial; Research; Research Personnel; Selection for Treatments; Services; Staging System; Statistical Data Interpretation; cancer therapy; data management; design; drug testing; improved; nonhuman primate; prognostic

The Section is the statistical and data management component of the Center for Cancer Research (CCR). The Section provides statistical leadership and data management consultation for major activities of the Center, and is involved in the design, conduct, monitoring, and statistical analyses of intramural and national multi-center clinical trials of experimental treatments for cancer, and intramural clinical trials for treatment of AIDS. The section provides a broad range of data analysis and consultation services to laboratories performing basic scientific research into the origin and growth mechanisms of cancer and AIDS. Other major collaborative efforts include studies to identify important prognostic and treatment selection factors, evaluate diagnostic procedures, develop improved staging systems, and assist investigators in the design, execution, and analyses of major in vitro drug testing studies. The Section develops and implements new statistical designs and biometric methods related to the development and evaluation of new cancer and AIDS treatments. Approximately 20 percent of the Section's activities are HIV/AIDS related.

该科是癌症研究中心的统计和数据管理部门。该科为中心的主要活动提供统计领导和数据管理咨询，并参与设计、实施、监测和统计分析校内和国家多中心癌症实验性治疗临床试验，以及校内治疗艾滋病的临床试验。该科为从事癌症和艾滋病起源和生长机制基础科研的实验室提供广泛的数据分析和咨询服务。其他主要的合作努力包括研究，以确定重要的预后和治疗选择因素，评估诊断程序，开发改进的分期系统，并协助研究人员在设计，执行和分析的主要体外药物试验研究。该科制定和实施与开发和评价新的癌症和艾滋病治疗方法有关的新的统计设计和生物鉴别方法。该科大约20%的活动与艾滋病毒/艾滋病有关。